Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–32.
Matsumoto C, Shinohara N, Furuta RA, Tanishige N, Shimojima M, Matsubayashi K, Nagai T, Tsubaki K, Satake M. Investigation of antibody to severe fever with thrombocytopenia syndrome virus (SFTSV) in blood samples donated in a SFTS-endemic area in Japan. Vox Sang. 2018;113(3):297–9.
Kim YR, Yun Y, Bae SG, Park D, Kim S, Lee JM, Cho NH, Kim YS, Lee KH. Severe fever with thrombocytopenia syndrome virus Infection, South Korea, 2010. Emerg Infect Dis. 2018;24(11):2103–5.
Tran XC, Yun Y, Van An L, Kim SH, Thao NTP, Man PKC, Yoo JR, Heo ST, Cho NH, Lee KH. Endemic severe fever with thrombocytopenia Syndrome, Vietnam. Emerg Infect Dis. 2019;25(5):1029–31.
Zohaib A, Zhang J, Saqib M, Athar MA, Hussain MH, Chen J, Sial AU, Tayyab MH, Batool M, Khan S, et al. Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan. Emerg Infect Dis. 2020;26(7):1513–6.
Sun J, Lu L, Wu H, Yang J, Ren J, Liu Q. The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011–2016. Sci Rep. 2017;7(1):9236.
Gai Z, Liang M, Zhang Y, Zhang S, Jin C, Wang SW, Sun L, Zhou N, Zhang Q, Sun Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2012;54(2):249–52.
Li H, Zhou Y, Wang W, Guo D, Huang S, Jie S. The clinical characteristics and outcomes of patients with human granulocytic anaplasmosis in China. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2011;15(12):e859–866.
Seo JW, Kim D, Yun N, Kim DM. Clinical update of severe fever with thrombocytopenia syndrome. Viruses 2021, 13(7).
Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, Oishi K. group-Japan ser: epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PLoS ONE. 2016;11(10):e0165207.
Hwang J, Kang JG, Oh SS, Chae JB, Cho YK, Cho YS, Lee H, Chae JS. Molecular detection of severe fever with thrombocytopenia syndrome virus (SFTSV) in feral cats from Seoul, Korea. Ticks tick-borne Dis. 2017;8(1):9–12.
Xu Y, Shao M, Liu N, Tang J, Gu Q, Dong D. Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study. Int J Infect Dis. 2021;105:646–52.
Bae S, Hwang HJ, Kim MY, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2020;70(7):1491–4.
Yoshikawa T, Fukushi S, Tani H, Fukuma A, Taniguchi S, Toda S, Shimazu Y, Yano K, Morimitsu T, Ando K, et al. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J Clin Microbiol. 2014;52(9):3325–33.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of Cancer/Invasive fungal infections cooperative group and the National Institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2008;46(12):1813–21.
Futagami T, Mori K, Kadooka C, Niihara H, Tashiro K, Tamaki H, Tanaka T. Chromosome-Level genome sequence of Aspergillus puulaauensis MK2, a fungus isolated from a dead hard tick. Microbiol Resour Announc. 2021;10(36):e0037221.
Song P, Zheng N, Zhang L, Liu Y, Chen T, Bao C, Li Z, Yong W, Zhang Y, Wu C, et al. Downregulation of Interferon-beta and Inhibition of TLR3 expression are associated with fatal outcome of severe fever with thrombocytopenia syndrome. Sci Rep. 2017;7(1):6532.
Deng B, Zhang S, Geng Y, Zhang Y, Wang Y, Yao W, Wen Y, Cui W, Zhou Y, Gu Q, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS ONE. 2012;7(7):e41365.
Liu Y, Fan L, Wang W, Song H, Zhang Z, Liu Q, Meng Z, Li S, Wang H, Zhou S, et al. A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study. Emerg Microbes Infect. 2025;14(1):2498572.
Jin C, Jiang H, Liang M, Han Y, Gu W, Zhang F, Zhu H, Wu W, Chen T, Li C, et al. SFTS virus infection in nonhuman primates. J Infect Dis. 2015;211(6):915–25.
Liu MY, He SF, Li YY, Shen JJ, Li JJ, Li YS, Liu YY, Wu T, Li JB, Hu LF. Alterations in the intestinal fungal Microbiome of patients with severe fever with thrombocytopenia syndrome. J Infect Public Health. 2025;18(9):102837.
Dai Y, Pu Q, Hu N, Zhu J, Han Y, Shi P, Li J, Jin K. The dose-response relationship between smoking and the risk factor for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome. Front Microbiol. 2023;14:1209705.
Song L, Zhao Y, Wang G, Zou W, Sai L. Investigation of predictors for invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome. Sci Rep. 2023;13(1):1538.
Hu L, Kong Q, Yue C, Xu X, Xia L, Bian T, Liu Y, Zhang H, Ma X, Yin H, et al. Early-Warning immune predictors for invasive pulmonary aspergillosis in severe patients with severe fever with thrombocytopenia syndrome. Front Immunol. 2021;12:576640.
Wang H, Luo M, Fisher D, Pronyuk K, Musabaev E, Thu HNT, Ye P, Zhao L. Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience. Front Microbiol. 2024;15:1448710.
Marano JM, Bosco-Lauth AM. Exploring routes of infection of severe fever with thrombocytopenia syndrome virus using experimentally infected animals. Am J Trop Med Hyg. 2025;112(5):1036–9.
Hiraki T, Yoshimitsu M, Suzuki T, Goto Y, Higashi M, Yokoyama S, Tabuchi T, Futatsuki T, Nakamura K, Hasegawa H, et al. Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in japan: a pathognomonic histological feature and unique complication of SFTS. Pathol Int. 2014;64(11):569–75.
Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA, McFadden G, Kubes P. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe. 2013;13(2):169–80.
Mitsios A, Arampatzioglou A, Arelaki S, Mitroulis I, Ritis K. NETopathies? Unraveling the dark side of old diseases through neutrophils. Front Immunol. 2016;7:678.
Zhang Y, Song R, Shen Y, Zhao Y, Zhao Z, Fan T, Yang X, Wang L, Zhang W, Chen C, et al. High levels of Circulating Cell-free DNA are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2020;70(9):1941–9.
Al-Harbi NO, Nadeem A, Ahmad SF, Alanazi MM, Aldossari AA, Alasmari F. Amelioration of sepsis-induced acute kidney injury through Inhibition of inflammatory cytokines and oxidative stress in dendritic cells and neutrophils respectively in mice: role of spleen tyrosine kinase signaling. Biochimie. 2019;158:102–10.
Pu Q, Dai Y, Hu N, Tao Z, Shi P, Jiang N, Shi L, Fang Z, Wang R, Hu X, et al. Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome. Virol J. 2024;21(1):179.
Liu H, Lin J, Phan QT, Bruno VM, Filler SG. Epidermal Growth Factor Receptor Signaling Governs the Host Inflammatory Response to Invasive Aspergillosis. bioRxiv 2024.
Wang D, Cao K, Shen X, Zhang B, Chen M, Yu W. Clinical characteristics and immune status of patients with severe fever with thrombocytopenia syndrome. Viral Immunol 2022.